AREV Life Sciences Global Statistics
Total Valuation
AREVF has a market cap or net worth of 317,624. The enterprise value is 423,813.
| Market Cap | 317,624 |
| Enterprise Value | 423,813 |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AREVF has 31.76 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 31.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 47.01% |
| Owned by Institutions (%) | n/a |
| Float | 16.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 59.60 |
| PB Ratio | -0.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.39 |
| EV / Sales | 79.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.12 |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.04 |
| Interest Coverage | -48.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -42.42% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 16.75% |
| Revenue Per Employee | 2,665 |
| Profits Per Employee | -88,539 |
| Employee Count | 2 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4,900.00% in the last 52 weeks. The beta is 6.85, so AREVF's price volatility has been higher than the market average.
| Beta (5Y) | 6.85 |
| 52-Week Price Change | +4,900.00% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 43.67 |
| Average Volume (20 Days) | 9,159 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AREVF had revenue of 5,329 and -177,077 in losses. Loss per share was -0.01.
| Revenue | 5,329 |
| Gross Profit | -9,436 |
| Operating Income | -144,016 |
| Pretax Income | -177,077 |
| Net Income | -177,077 |
| EBITDA | -127,122 |
| EBIT | -144,016 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1,344 in cash and 107,530 in debt, giving a net cash position of -106,186 or -0.00 per share.
| Cash & Cash Equivalents | 1,344 |
| Total Debt | 107,530 |
| Net Cash | -106,186 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -859,810 |
| Book Value Per Share | -0.03 |
| Working Capital | -966,632 |
Cash Flow
In the last 12 months, operating cash flow was -111,911 and capital expenditures 9,005, giving a free cash flow of -102,906.
| Operating Cash Flow | -111,911 |
| Capital Expenditures | 9,005 |
| Free Cash Flow | -102,906 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | -177.06% |
| Operating Margin | -2,702.50% |
| Pretax Margin | -3,322.89% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AREVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.28% |
| Shareholder Yield | -33.28% |
| Earnings Yield | -55.75% |
| FCF Yield | -32.40% |
Stock Splits
The last stock split was on March 19, 2020. It was a reverse split with a ratio of 0.1666666.
| Last Split Date | Mar 19, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1666666 |
Scores
AREVF has an Altman Z-Score of -125.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -125.6 |
| Piotroski F-Score | n/a |